SLC22A1 and hepatocellular carcinoma: Compared with other cancers, one may anticipate a greater effect of metformin on HCC, given that organic cation transporter 1 (SLC22A1) is highly expressed in hepatocytes and can enable increased uptake of metformin in the liver.16 However, little is known about the effects of metformin on HCC mortality.